Insignificant transfer of glyburide occurs across the human placenta

Byron D. Elliott, Oded Langer, Steve Schenker, Raymond F. Johnson

Research output: Contribution to journalArticlepeer-review

161 Scopus citations


No data exist concerning human placental transfer of oral hypoglycemic agents during pregnancy. This study characterizes the transport of glyburide in 10 term human placentas with the single-cotyledon placental model. Serial samples were taken from both the maternal and fetal reservoirs during each 3-hour perfusion, and the percent transport and metabolism of tritiated glyburide was calculated with liquid scintillation spectrometry and high-performance liquid chromatography. Antipyrine labeled with carbon 14 was added to the perfusate solution during these experiments as a control. Virtually no transfer of glyburide occurred, and no appreciable metabolism of the drug was detected. Neither variation in the albumin concentration nor increase in the maternal glyburide levels to 100 times therapeutic concentration materially altered the rate of transport. These data show that insignificant transport of glyburide occurs across the human placenta in vitro and suggest that fetal exposure to maternally administered glyburide likewise may be insignificant.

Original languageEnglish (US)
Pages (from-to)807-812
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Issue number4 PART 1
StatePublished - Oct 1991
Externally publishedYes


  • diazepam
  • Glyburide
  • placenta
  • pregnancy, human

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Insignificant transfer of glyburide occurs across the human placenta'. Together they form a unique fingerprint.

Cite this